Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese

Clinical Endocrinology

Volumn 75, Issue 2, 2011, Pages 240-246

  Xu, Chengfu ^a   Xu, Lei ^b   Yu, Chaohui ^a   Miao, Min ^c   Li, Youming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b NINGBO FIRST HOSPITAL   (China)

^c Zhenhai Lianhua Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; URIC ACID;

AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERURICEMIA; LIVER EXAMINATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 79960189855     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04016.x     Document Type: Article

References (41)

1. Neuschwander-Tetri, B.A., &, Caldwell, S.H., (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology, 37, 1202-1219. (Pubitemid 36538699)
2. Bedogni, G., Miglioli, L., Masutti, F., et al. (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology, 42, 44-52. (Pubitemid 40911310)
3. Fan, J.G., &, Farrell, G.C., (2009) Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology, 50, 204-210.
4. Das, K., Das, K., Mukherjee, P.S., et al. (2010) Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology, 51, 1593-1602.
5. Pagano, G., Pacini, G., Musso, G., et al. (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology, 35, 367-372. (Pubitemid 34106376)
6. Marchesini, G., Bugianesi, E., Forlani, G., et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 37, 917-923. (Pubitemid 36397405)
7. Marchesini, G., Brizi, M., Bianchi, G., et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes, 50, 1844-1850. (Pubitemid 33641605)
8. Parekh, S., &, Anania, F.A., (2007) Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology, 132, 2191-2207. (Pubitemid 46693752)
9. Xu, C.F., Yu, C.H., Li, Y.M., et al. (2007) Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease. World Journal of Gastroenterology, 13, 4504-4508.
10. Day, C.P., (2010) Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Digestive Diseases, 28, 255-260.
11. Browning, J.D., Szczepaniak, L.S., Dobbins, R., et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 40, 1387-1395. (Pubitemid 39657013)
12. Zelber-Sagi, S., Nitzan-Kaluski, D., Halpern, Z., et al. (2006) Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver International, 26, 856-863. (Pubitemid 44165254)
13. Angulo, P., Keach, J.C., Batts, K.P., et al. (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology, 30, 1356-1362.
14. Adams, L.A., Lymp, J.F., St, S.J., et al. (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology, 129, 113-121. (Pubitemid 41002048)
15. Frith, J., Day, C.P., Henderson, E., et al. (2009) Non-alcoholic fatty liver disease in older people. Gerontology, 55, 607-613.
16. Aoki, Y., Belin, R.M., Clickner, R., et al. (2007) Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid, 17, 1211-1223.
17. Antonelli, A., Ferri, C., Pampana, A., et al. (2004) Thyroid disorders in chronic hepatitis C. American Journal of Medicine, 117, 10-13. (Pubitemid 38798015)
18. Hassan, M.M., Kaseb, A., Li, D., et al. (2009) Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology, 49, 1563-1570.
19. Silveira, M.G., Mendes, F.D., Diehl, N.N., et al. (2009) Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver International, 29, 1094-1100.
20. Liangpunsakul, S., &, Chalasani, N., (2003) Is hypothyroidism a risk factor for non-alcoholic steatohepatitis. Journal of Clinical Gastroenterology, 37, 340-343. (Pubitemid 37158998)
21. Uzunlulu, M., Yorulmaz, E., &, Oguz, A., (2007) Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocrine Journal, 54, 71-76. (Pubitemid 46481674)
22. Cable, E.E., Finn, P.D., Stebbins, J.W., et al. (2009) Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology, 49, 407-417.
23. Perra, A., Simbula, G., Simbula, M., et al. (2008) Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. The FASEB Journal, 22, 2981-2989.
24. Li, Y., Xu, C., Yu, C., et al. (2009) Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. Journal of Hepatology, 50, 1029-1034.
25. Xu, C., Yu, C., Xu, L., et al. (2010) High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS ONE, 5, e11578.
26. Cerda, C., Perez-Ayuso, R.M., Riquelme, A., et al. (2007) Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Journal of Hepatology, 47, 412-417. (Pubitemid 47176161)
27. Hamaguchi, M., Kojima, T., Takeda, N., et al. (2005) The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Annals of Internal Medicine, 143, 722-728.
28. Zeng, M.D., Fan, J.G., Lu, L.G., et al. (2008) Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. Journal of Digestive Diseases, 9, 108-112. (Pubitemid 351566633)
29. Alberti, K.G., Zimmet, P., &, Shaw, J., (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine, 23, 469-480.
30. Knudsen, N., Laurberg, P., Rasmussen, L.B., et al. (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism, 90, 4019-4024. (Pubitemid 41058166)
31. Roos, A., Bakker, S.J., Links, T.P., et al. (2007) Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. Journal of Clinical Endocrinology and Metabolism, 92, 491-496.
32. Lin, S.Y., Wang, Y.Y., Liu, P.H., et al. (2005) Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metabolism, 54, 1524-1528.
33. Shon, H.S., Jung, E.D., Kim, S.H., et al. (2008) Free T4 is negatively correlated with body mass index in euthyroid women. The Korean Journal of Internal Medicine, 23, 53-57. (Pubitemid 351890855)
34. Puri, P., Baillie, R.A., Wiest, M.M., et al. (2007) A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology, 46, 1081-1090. (Pubitemid 350144772)
35. Goldberg, I.J., &, Ginsberg, H.N., (2006) Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology, 130, 1343-1346.
36. Sookoian, S., &, Pirola, C.J., (2008) Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. Journal of Hepatology, 49, 600-607.
37. Targher, G., Marra, F., &, Marchesini, G., (2008) Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon. Diabetologia, 51, 1947-1953.
38. Hak, A.E., Pols, H.A., Visser, T.J., et al. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine, 132, 270-278. (Pubitemid 30106257)
39. Cappola, A.R., &, Ladenson, P.W., (2003) Hypothyroidism and atherosclerosis. Journal of Clinical Endocrinology and Metabolism, 88, 2438-2444. (Pubitemid 36724408)
40. Joy, D., Thava, V.R., &, Scott, B.B., (2003) Diagnosis of fatty liver disease: is biopsy necessary. European Journal of Gastroenterology and Hepatology, 15, 539-543. (Pubitemid 36571048)
41. Sanyal, A.J., (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 123, 1705-1725. (Pubitemid 35231670)